Fig. 1 · Structure
Documents & Downloads
SDZ NVI 085
α1-Adrenoceptor Subtype Agonist
SDZ NVI 085 is an α1-adrenoceptor subtype agonist known for its central nervous system stimulatory effects. This compound exhibits anti-cataplexy and anti-stroke activities, enhancing alertness and combating excessive sleepiness. SDZ NVI 085 serves as a valuable tool for research exploring sleep-related disorders and the mechanisms of arousal.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 104195-17-7 |
| Applications | α1-Adrenoceptor Subtype Agonist |
| Formula | C15H21NO2S |
| Molecular Weight | 279.40 |
| SMILES | CSC1=CC=C(OC)C2=C1C[C@@]3([H])OCCN(C)[C@]3([H])C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.